{
  "docId": "019de074-ddab-749d-b286-5e01e8bcb935",
  "docSlug": "f43e68719e672319f390e5844d5bc5fe",
  "documentTitle": "Chimerix | Investor Presentation Deck | 41 slides",
  "authorId": "chimerix",
  "authorName": "Chimerix",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 37,
  "pageCount": 41,
  "prevPage": 36,
  "nextPage": 38,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "Includes a dot plot showing significant reduction in viral lung titer across various treatment initiation times compared to vehicle.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-ddab-749d-b286-5e01e8bcb935/37",
  "deckHref": "/decks/019de074-ddab-749d-b286-5e01e8bcb935",
  "deckJsonHref": "/decks/019de074-ddab-749d-b286-5e01e8bcb935.json",
  "deckAnchorHref": "/decks/019de074-ddab-749d-b286-5e01e8bcb935#slide-37",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.644,
        "x": 0.038,
        "y": 0.76
      },
      "kind": "callout",
      "text": "$2 million grant to fund prodrug formulations that could enable oral administration with improved lung delivery",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6c2581a5-182f-44d5-b519-dba33c61eb83",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.28,
        "x": 0.675,
        "y": 0.165
      },
      "kind": "chart",
      "text": "Viral Lung Titer Replicating SARS-COV-2-MA10",
      "attrs": null,
      "subkind": "dot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "60e0435c-ebcc-4199-8362-d583160082e4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.105,
        "w": 0.605,
        "x": 0.065,
        "y": 0.222
      },
      "kind": "list",
      "text": "Ribonucleoside analog that is a viral polymerase inhibitor; Inhaled nebulized liquid aerosol formulation; minimal systemic exposure",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "33d3df25-c2de-41fb-a2e0-c45654d1c2f3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.605,
        "x": 0.065,
        "y": 0.333
      },
      "kind": "list",
      "text": "Monotherapy efficacy in mouse-adapted SARS-CoV-2-MA10 model across multiple endpoints: Lung viral titer, Viral RNA, Clinical scoring, Lung pathology, Animal weight loss",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50e86f26-b153-4f08-9c0d-1d49643bcc8e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.62,
        "x": 0.105,
        "y": 0.938
      },
      "kind": "subtitle",
      "text": "1. Replicates lung pathology of human infection 4-days post-infection. One day in mouse is 5-7 days in humans (adjusted disease course).",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a04f9888-bb10-4a9f-ad37-861e137e2adc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.038,
        "w": 0.624,
        "x": 0.188,
        "y": 0.065
      },
      "kind": "title",
      "text": "CMX-521: anti-SARS-CoV-2 preclinical activity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "134c05f9-572c-47d3-aaab-ac024aa2a905",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "20c255ab-f9f9-4407-afb5-e59d6e06f265",
      "evidence": "list/bullet: Monotherapy efficacy in mouse-adapted SARS-CoV-2-MA10 model across multiple endpoints: Lung viral titer, Viral RNA, Clinical scoring, Lung pathology, Animal weight loss",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}